The Significance of Preclinical Evaluation of Sirolimus-, Paclitaxel-, and Zotarolimus-Eluting Stents

This publication has 37 references indexed in Scilit:

• Overview of Pharmacology and Clinical Trials Program with the Zotarolimus‐Eluting Endeavor Stent
  Journal of Interventional Cardiology, 2006
• Pathology of Drug-Eluting Stents in Humans
  Journal of the American College of Cardiology, 2006
• Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks
  European Heart Journal, 2006
• Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents
  Circulation, 2005
• Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation
  Journal of the American College of Cardiology, 2005
• Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
  New England Journal of Medicine, 2003
• Time Course of Stent Endothelialization After Intravascular Radiation Therapy in Rabbit Iliac Arteries
  Circulation, 2003
• Drug eluting stents: are human and animal studies comparable?
  Heart, 2003
• Influence of Topography on Endothelialization of Stents: Clues for New Designs
  Journal of Long-Term Effects of Medical Implants, 2000
• Pathobiologic Responses to Stenting 11Supported in part by grants from the National Institutes of Health (GM/HL49039 and HL03104), the Burroughs Wellcome Fund for Experimental Therapeutics, Durham, North Carolina, and the Whitaker Foundation, Rosslyn, Virginia.
  The American Journal of Cardiology, 1998